Differential Diagnosis of Dementia with Lewy Bodies and Alzheimer Disease Using Combined MR Imaging and Brain Perfusion Single-Photon Emission Tomography

References

1. 1.↵
   1. McKeith IG,
   2. Dickson DW,
   3. Lowe J,
   4. et al

   . Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65: 1863–72. Epub 2005 Oct 19

   CrossRef
2. 2.↵
   1. Hansen L,
   2. Salmon D,
   3. Galasko D,
   4. et al

   . The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990; 40: 1–8
3. 3.↵
   1. Kosaka K

   . Diffuse Lewy body disease in Japan. J Neurol 1990; 237: 197–204

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Galasko D

   . Lewy bodies and dementia. Curr Neurol Neurosci Rep 2001; 1: 435–41

   CrossRefPubMed
5. 5.↵
   1. Zesiewicz TA,
   2. Baker MJ,
   3. Dunne PB,
   4. et al

   . Diffuse Lewy body disease. Curr Treat Options Neurol 2001; 3: 507–18

   CrossRefPubMed
6. 6.↵
   1. Doubleday EK,
   2. Snowden JS,
   3. Varma AR,
   4. et al

   . Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 72: 602–07

   Abstract/FREE Full Text
7. 7.↵
   1. Mega MS,
   2. Lee L,
   3. Dinov ID,
   4. et al

   . Cerebral correlates of psychotic symptoms in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000; 69: 167–71

   Abstract/FREE Full Text
8. 8.↵
   1. Ishii K,
   2. Imamura T,
   3. Sasaki M,
   4. et al

   . Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 1998; 51: 125–30

   CrossRef
9. 9.↵
   1. Ishii K,
   2. Yamaji S,
   3. Kitagaki H,
   4. et al

   . Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 1999; 53: 413–16

   CrossRef
10. 10.↵
    1. Lobotesis K,
    2. Fenwick JD,
    3. Phipps A,
    4. et al

    . Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001; 56: 643–49

    CrossRef
11. 11.↵
    1. Ransmayr G,
    2. Seppi K,
    3. Donnemiller E,
    4. et al

    . Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease. Eur J Nucl Med 2001; 28: 1523–28

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Piggott MA,
    2. Marshall EF,
    3. Thomas N,
    4. et al

    . Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 1999; 122: 1449–68

    Abstract/FREE Full Text
13. 13.↵
    1. Petrella JR,
    2. Coleman RE,
    3. Doraiswamy PM

    . Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. Radiology 2003; 226: 315–36

    PubMedWeb of Science
14. 14.↵
    1. Ishii K,
    2. Soma T,
    3. Kono AK,
    4. et al

    . Comparison of regional brain volume and glucose metabolism between patients with mild dementia with Lewy bodies and those with mild Alzheimer's disease. J Nucl Med 2007; 48: 704–11

    Abstract/FREE Full Text
15. 15.↵
    1. McKhann G,
    2. Drachman D,
    3. Folstein M,
    4. et al

    . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939–44

    CrossRefPubMed
16. 16.↵
    1. McKeith IG,
    2. Galasko D,
    3. Kosaka,
    4. et al

    . Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113–24

    CrossRef
17. 17.↵
    1. Cummings JL,
    2. Mega M,
    3. Gray K,
    4. et al

    . The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308–14

    CrossRefPubMed
18. 18.↵
    1. Defebvre LJ,
    2. Leduc V,
    3. Duhamel A,
    4. et al

    . Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med 1999; 40: 956–62

    Abstract/FREE Full Text
19. 19.↵
    1. Minoshima S,
    2. Foster NL,
    3. Sima AA,
    4. et al

    . Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001; 50: 358–65

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Shimizu S,
    2. Hanyu H,
    3. Kanetaka H,
    4. et al

    . Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. Dement Geriatr Cogn Disord 2005; 20: 25–30

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Pasquier J,
    2. Michel BF,
    3. Brenot-Rossi I,
    4. et al

    . Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging 2002; 29: 1342–48. Epub 2002 Jul 31

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Charpentier P,
    2. Lavenu I,
    3. Defebvre L,
    4. et al

    . Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to ^99mTc HmPAO SPECT data. J Neurol Neurosurg Psychiatry 2000; 69: 661–63

    Abstract/FREE Full Text
23. 23.↵
    1. McNeill R,
    2. Sare GM,
    3. Manoharan M,
    4. et al

    . Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78: 350–55

    Abstract/FREE Full Text
24. 24.↵
    1. Sjögren M,
    2. Gustafson L,
    3. Wikkelsö C,
    4. et al

    . Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio. Dement Geriatr Cogn Disord 2000; 11: 275–85

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Colloby SJ,
    2. Fenwick JD,
    3. Williams ED,
    4. et al

    . A comparison of ^99mTc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging 2002; 29: 615–22. Epub 2002 Mar 5

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Kemp PM,
    2. Hoffmann SA,
    3. Tossici-Bolt L,
    4. et al

    . Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nucl Med Commun 2007; 28: 451–56

    CrossRefPubMed
27. 27.↵
    1. O'Brien JT

    . Role of imaging techniques in the diagnosis of dementia. Br J Radiol 2007; 80: S71–77

    Abstract/FREE Full Text
28. 28.↵
    1. McKeith I,
    2. O'Brien J,
    3. Walker Z,
    4. et al

    . Sensitivity and specificity of dopamine transporter imaging with ¹²³I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007; 6: 305–13

    CrossRefPubMedWeb of Science
29. 29.↵
    1. O'Brien JT,
    2. Colloby S,
    3. Fenwick J,
    4. et al

    . Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004; 61: 919–25

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Colloby SJ,
    2. Firbank MJ,
    3. Pakrasi S,
    4. et al

    . A comparison of ^99mTc-exametazime and ¹²³I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. Int Psychogeriatr 2008; 20: 1124–40

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Colloby SJ,
    2. Williams ED,
    3. Burn DJ,
    4. et al

    . Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using ¹²³I-FP-CIT SPECT. Eur J Nucl Med Mol Imaging 2005; 32: 1176–85. Epub 2005 Jun 2

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Tatsch K

    . Imaging of the dopaminergic system in differential diagnosis of dementia. Eur J Nucl Med Mol Imaging 2008; 35 (suppl 1): S51–57

    CrossRefPubMed
33. 33.↵
    1. O'Brien JT,
    2. McKeith IG,
    3. Walker Z,
    4. et al

    . Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 2009; 194: 34–39

    Abstract/FREE Full Text
34. 34.↵
    1. Dougall NJ,
    2. Bruggink S,
    3. Ebmeier KP

    . Systematic review of the diagnostic accuracy of ^99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry 2004; 12: 554–70

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Ishii K,
    2. Hosaka K,
    3. Mori T,
    4. et al

    . Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies. Ann Nucl Med 2004; 18: 447–51.

    PubMedWeb of Science
36. 36.↵
    1. Hanyu H,
    2. Shimizu S,
    3. Hirao K,
    4. et al

    . Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2006; 33: 248–53

    CrossRefPubMed
37. 37.↵
    1. Hanyu H,
    2. Shimizu S,
    3. Hirao K,
    4. et al

    . Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT. J Neurol Sci 2006; 250: 97–102

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Kitayama N,
    2. Matsuda H,
    3. Ohnishi T,
    4. et al

    . Measurements of both hippocampal blood flow and hippocampal gray matter volume in the same individuals with Alzheimer's disease. Nucl Med Commun 2001; 22: 473–77

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Barber R,
    2. McKeith I,
    3. Ballard C,
    4. et al

    . Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. J Neurol Neurosurg Psychiatry 2002; 72: 406–07

    Abstract/FREE Full Text
40. 40.↵
    1. Almeida OP,
    2. Burton EJ,
    3. McKeith I,
    4. et al

    . MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2003; 16: 57–63

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Rombouts SA,
    2. Barkhof F,
    3. Witter MP,
    4. et al

    . Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000; 285: 231–33

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Whitwell JL,
    2. Weigand SD,
    3. Shiung MM,
    4. et al

    . Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 2007; 130: 708–19

    Abstract/FREE Full Text
43. 43.↵
    1. Cousins DA,
    2. Burton EJ,
    3. Burn D,
    4. et al

    . Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study. Neurology 2003; 61: 1191–95

    CrossRef
44. 44.↵
    1. Katsuse O,
    2. Iseki E,
    3. Marui W,
    4. et al

    . Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci 2003; 211: 29–35

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Higuchi M,
    2. Tashiro M,
    3. Arai H,
    4. et al

    . Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies. Exp Neurol 2000; 162: 247–56

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Zaja-Milatovic S,
    2. Keene CD,
    3. Montine KS,
    4. et al

    . Selective dendritic degeneration of medium spiny neurons in dementia with Lewy bodies. Neurology 2006; 66: 1591–93

    CrossRef
47. 47.↵
    1. Zaja-Milatovic S,
    2. Milatovic D,
    3. Schantz AM,
    4. et al

    . Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 2005; 64: 545–47

    CrossRef
48. 48.↵
    1. Lisanby SH,
    2. McDonald WM,
    3. Massey EW,
    4. et al

    . Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. J Neural Transm Suppl 1993; 40: 13–21

    PubMed
49. 49.↵
    1. Krabbe K,
    2. Karlsborg M,
    3. Hansen A,
    4. et al

    . Increased intracranial volume in Parkinson's disease. J Neurol Sci 2005; 239: 45–52

    CrossRefPubMed
50. 50.↵
    1. Geng DY,
    2. Li YX,
    3. Zee CS

    . Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease. Neurosurgery 2006; 58: 256–62

    CrossRefPubMedWeb of Science
51. 51.↵
    1. Jack CR Jr.,
    2. Petersen RC,
    3. O'Brien PC,
    4. et al

    . MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology 1992; 42: 183–88

    CrossRef
52. 52.↵
    1. Pennanen C,
    2. Kivipelto M,
    3. Tuomainen S,
    4. et al

    . Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging 2004; 25: 303–10

    CrossRefPubMedWeb of Science
53. 53.↵
    1. Barber R,
    2. Gholkar A,
    3. Scheltens P,
    4. et al

    . Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999; 52: 1153–58

    CrossRef